Subramonia Pillai

Title: Subramonia Pillai: Innovator in Immunogenic Conjugates

Introduction

Subramonia Pillai is a notable inventor based in Rochester, NY, who has made significant contributions to the field of immunology. He holds three patents that focus on innovative approaches to vaccine development and immunogenicity enhancement. His work has the potential to improve vaccine efficacy and safety.

Latest Patents

One of his latest patents is titled "Synthetic peptides representing a T-cell epitope as a carrier molecule." This invention relates to novel T-cell epitopes derived from bacterial products. The epitopes can be utilized in the preparation of conjugates with medically useful antigens, haptens, or antigenic determinants. These conjugates are designed to elicit antibody responses similar to those of antigens covalently coupled to carrier proteins, thereby providing a safe and more economical option for conjugate vaccines.

Another significant patent is "Cytokine and hormone carriers for conjugate vaccines." This invention involves immunogenic conjugates that comprise a carbohydrate-containing antigen or other antigens bound to or genetically fused with a cytokine, lymphokine, hormone, or growth factor that has immunomodulating activity. The cytokine or lymphokine can be an interleukin or an interferon, and these immunogenic conjugates can be utilized in vaccine and co-vaccine formulations.

Career Highlights

Throughout his career, Subramonia Pillai has worked with prominent companies in the biotechnology and pharmaceutical sectors. He has been associated with Praxis Biologics, Inc. and American Cyanamid Company, where he contributed to various research and development projects.

Collaborations

Subramonia has collaborated with notable professionals in his field, including Robert N Brey, III and William R Majarian. These collaborations have likely enriched his research and contributed to the advancement of his inventions.

Conclusion

Subramonia Pillai's innovative work in the field of immunogenic conjugates showcases his commitment to enhancing vaccine technology. His patents reflect a deep understanding of immunology and a dedication to improving public health through scientific advancements.